Effects of Different Wrist Positions in Dorsal Blocking Orthoses After Flexor Tendon Repair
Condition(s) studied
Investigational drug(s) / intervention(s)
3D-Printed Dorsal Blocking Orthosis (wrist 30 degree extension): Participants will use a 3D-printed dorsal blocking orthosis with the wrist positioned at 30° extension and follow a controlled early active mobilization protocol.
3D-Printed Dorsal Blocking Orthosis (wrist neutral): Participants will use a 3D-printed dorsal blocking orthosis with the wrist in neutral position and follow the same rehabilitation protocol.
3D-Printed Dorsal Blocking Orthosis (wrist 30 degree flexion): Participants will use a 3D-printed dorsal blocking orthosis with the wrist positioned at 30° flexion and follow the same rehabilitation protocol.
Study summary
This randomized controlled study aims to compare the effects of three different wrist positions (30° extension, neutral, and 30° flexion) used in dorsal blocking orthoses during early active mobilization after zone I-II flexor tendon repair. A total of 54 patients will be randomly assigned into three groups. All participants will receive the same rehabilitation protocol. Clinical and functional outcomes including total active motion, pain, complications, functional status, and orthosis satisfaction will be evaluated at 6, 8, and 12 weeks by a blinded assessor.
Eligibility
Primary outcome measure(s)
- Total Active Motion (TAM) — 12 week
Total active motion will be calculated by summing the active flexion angles of the metacarpophalangeal, proximal interphalangeal, and distal interphalangeal joints and subtracting any extension deficits. Measurements will be performed using a finger goniometer and evaluated according to the Buck-Gramcko classification.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Gazi University | Ankara | Turkey (Türkiye) | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07489235 on ClinicalTrials.gov ↗ ← All trials in Turkey